Next report date
Report period
Q1 2024
EPS estimate
−0.77SEK
Revenue estimate
144.40 MSEK
−3.74SEK
−128.30 MSEK
638.80 MSEK
19.60 M
About OREXO AB
Sector
CEO
Nikolaj Sørensen
Headquarters
Uppsala
Website
Employees (FY)
116
Founded
1994
ISIN
SE0000736415
FIGI
BBG00SY8PZ35
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. It operates through the following segments: US Pharma, Digital Therapeutics (DTx), and HQ and Pipelines. The US Pharma segment include sales of own pharmaceuticals in the US. The DTx segment comprises digital therapeutic venture. The HQ and Pipeline segment focuses in the out-licensed pharmaceuticals and costs for research and development, business development, global regulatory, and supply chain. The company was founded by Thomas Lundqvist on November 18, 1994 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0H19 is 16.18 SEK — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange OREXO AB NPV stocks are traded under the ticker 0H19.
OREXO AB NPV is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0H19 stock is 0% volatile and has beta coefficient of 0.24. Check out the list of the most volatile stocks — is OREXO AB NPV there?
0H19 earnings for the last quarter are −0.97 SEK per share, whereas the estimation was −0.92 SEK resulting in a −5.43% surprise. The estimated earnings for the next quarter are −0.47 SEK per share. See more details about OREXO AB NPV earnings.
OREXO AB NPV revenue for the last quarter amounts to 156.10 M SEK despite the estimated figure of 154.30 M SEK. In the next quarter revenue is expected to reach 150.40 M SEK.
Yes, you can track OREXO AB NPV financials in yearly and quarterly reports right on TradingView.
0H19 stock has fallen by 1.46% compared to the previous week, the month change is a 7.79% rise, over the last year OREXO AB NPV has showed a 39.48% increase.
0H19 net income for the last quarter is −18.60 M SEK, while the quarter before that showed −33.30 M SEK of net income which accounts for 44.14% change. Track more OREXO AB NPV financial stats to get the full picture.
Today OREXO AB NPV has the market capitalization of 582.20 M, it has decreased by 6.74% over the last week.
No, 0H19 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0H19 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OREXO AB NPV stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 116.00 employees. See our rating of the largest employees — is OREXO AB NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OREXO AB NPV technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OREXO AB NPV stock shows the neutral signal. See more of OREXO AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OREXO AB NPV EBITDA is −46.60 M SEK, and current EBITDA margin is −7.14%. See more stats in OREXO AB NPV financial statements.